Advertisement

Topics

Rosetta Genomics Company Profile

04:15 EDT 25th June 2018 | BioPortfolio

Rosetta Genomics is a leading developer of microRNA-based molecular diagnostics. Founded in 2000, the company’s integrative research platform combining bioinformatics and state-of-the-art laboratory processes has led to the discovery of hundreds of biologically validated novel human microRNAs. Building on its strong patent position and proprietary platform technologies, Rosetta Genomics is working on the application of these technologies in the development of a full range of microRNA-based diagnostic tools. The company’s first three microRNA-based tests, miRview™ squamous, miRview™ mets and miRview™ meso, are commercially available through its Philadelphia-based CAP-accredited, CLIA-certified lab. Rosetta Genomics is the 2008 winner of the Wall Street Journal’s Technology Innovation Awards in the medical/biotech category. To learn more, please visit www.rosettagenomics.com.

Location

10 Plaut St.,
Rehovot
76706
Israel

Contact

Phone: +972 8 948 4755
Fax: +972 8 948 4766


News Articles [309 Associated News Articles listed on BioPortfolio]

Rosetta Genomics Ltd.: Genoptix Completes Acquisition of PersonalizeDx from Rosetta Genomics

-First step in the process of Genoptix acquiring all of Rosetta Genomics -Next step is the completion of a merger for $8 million in cash pursuant to which value to Rosetta Genomics' equity holders...

Rosetta Genomics Ltd.: Rosetta Announces That Completion of Genoptix Transaction Uncertain

Rosetta Contemplates Bankruptcy Filing May 31, 2018 PHILADELPHIA, PA and REHOVOT, ISRAEL / ACCESSWIRE / May 29, 2018 / Rosetta Genomics Ltd. (NASDAQ: ROSG; OTC PINK: ROSGF)(the "Company") announce...

Rosetta Genomics Ltd.: Rosetta Genomics Announces Shareholder Approval of Merger with Genoptix

PHILADELPHIA, PA and REHOVOT, ISRAEL / ACCESSWIRE / April 26, 2018 / Rosetta Genomics Ltd. (the "Company") (NASDAQ: ROSG) today announced that its shareholders approved a proposed merger with a sub...

Rosetta Genomics Ltd.: Rosetta Announces Resignation of CEO

PHILADELPHIA, PA and REHOVOT, ISRAEL / ACCESSWIRE / April 10, 2018 / Rosetta Genomics Ltd. (NASDAQ: ROSG), a genomic diagnostics company that improves treatment decisions by providing timely and a...

ValuEngine Upgrades Rosetta Genomics (ROSG) to Sell

Separately, Barrington Research cut Rosetta Genomics from an "outperform" rating to a "market perform" rating in a research report on Monday, December 18th. Rosetta Genomics traded down $0.06 during t...

Rosetta Genomics Ltd.: Nasdaq Hearing Panel Determined to Delist Shares of Rosetta Genomics from Nasdaq Stock Market Effective May 22, 2018

PHILADELPHIA, PA and REHOVOT, ISRAEL / ACCESSWIRE / May 18, 2018 / Rosetta Genomics Ltd. (the "Company") (NASDAQ: ROSG) announced today that on May 18, 2018, it received a decision letter from NASD...

$9M Genoptix merger OK'd by Rosetta Genomics shareholders

Genoptix's proposed acquisition of Rosetta Genomics, valued at $9 million, received approval from Rosetta's shareholders.  -More- 

Genoptix plans to acquire Rosetta Genomics for $10mm in cash; transaction later terminated

Oncology diagnostic lab Genoptix Inc. agreed to acquire all outstanding shares of Nasdaq-traded Israeli genomics company Rosetta Genomics Ltd. (cancer diagnostics).

Drugs and Medications [0 Results]

None

PubMed Articles [251 Associated PubMed Articles listed on BioPortfolio]

Rosetta Protein Structure Prediction from Hydroxyl Radical Protein Footprinting Mass Spectrometry Data.

In recent years mass spectrometry-based covalent labeling techniques such as hydroxyl radical footprinting (HRF) have emerged as valuable structural biology techniques, yielding information on protein...

Genomics Education: Knowledge of Nurses Across the Profession and Integration Into Practice.

Since the completion of the Human Genome Project in 2003, the implications of genetics and genomics for health and illness have become clearer. All nurses, at all levels and across all specialties, mu...

Recent developments of software and database in microbial genomics and functional genomics.

Genetics and Genomics: An Oncology Nurse's Journey in Practice.

Cancer genetics and genomics are now an integral component of oncology care. Genetics and genomics guide recommendations not only for cancer prevention and early detection, but also for cancer treatme...

The Global Landscape of Nursing and Genomics.

Nurses have a pivotal role in bringing the benefits of genomics and precision medicine to everyday health care, but a concerted global effort is needed to transform nursing policy and practice to addr...

Clinical Trials [82 Associated Clinical Trials listed on BioPortfolio]

RandOmized Study Exploring the Combination of radioTherapy With Two Types of Acupuncture Treatment: The ROSETTA Trial

The ROSETTA-trial will evaluate the effect of acupuncture as a complementary treatment parallel to radiation therapy in oncological patients. The trial is designed as a two-armed trial. De...

Electronic Medical Records and Genomics (eMERGE) Phase III

The Electronic Medical Records and Genomics (eMERGE) Network is in its third phase and during this time is enrolling and sequencing 25,000 individuals on a custom sequencing panel of clini...

Genomics and Postoperative Atrial Fibrillation

This research study is done to find out if genetic make up of a person plays a role in complications and recovery after the Coronary Artery Bypass Graft (CABG) operation. As you may be aw...

Microfluidics and Transcriptomics in Post Solid Organ Transplant Patients

The field of genomics is an exciting new field being applied in medicine. Its use in treating some cancers, sepsis and burn patients has been very promising. As knowledge of genomics and a...

High Throughput Drug Sensitivity and Genomics Data in Developing Individualized Treatment in Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia

This pilot clinical trial studies whether using high throughput drug sensitivity and genomics data is feasible in developing individualized treatment in patients with multiple myeloma or p...

Companies [405 Associated Companies listed on BioPortfolio]

Rosetta Genomics

Rosetta Genomics is a leading developer of microRNA-based molecular diagnostics. Founded in 2000, the company’s integrative research platform combining bioinformatics and sta...

Rosetta Genomics, Ltd.

Rosetta Genomics is a leading developer of microRNA-based molecular diagnostics. Founded in 2000, the company’s integrative research platform combining bioinformatics and sta...

Rosetta Genomics Ltd.

Rosetta Genomics (NASDAQ: ROSG) is a leading developer of microRNA-based molecular diagnostics. Founded in 2000, the company’s integrative research platform combining bioinfo...

Rosetta Genomics Ltd. and Biocept, Inc.

Rosetta develops and commercializes a full range of microRNA-based and other molecular diagnostics. Rosetta’s integrative research platform combining bioinformatics and state...

Rosetta Stone Inc.

Rosetta Stone Inc. is changing the way the world learns languages. Rosetta Stone provides interactive solutions that are acclaimed for the speed and power to unlock the natural la...

More Information about "Rosetta Genomics" on BioPortfolio

We have published hundreds of Rosetta Genomics news stories on BioPortfolio along with dozens of Rosetta Genomics Clinical Trials and PubMed Articles about Rosetta Genomics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Rosetta Genomics Companies in our database. You can also find out about relevant Rosetta Genomics Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Prostate Cancer
Prostate cancer (cancer de prostata) Prostate cancer (cancer de prostata) is a form of cancer that develops in the prostate, a gland in the male reproductive system. Most prostate cancers are slow growing; however, there are cases of aggressive prostat...


Corporate Database Quicklinks



Searches Linking to this Company Record